MSH2 and adenocarcinoma: Compared to K-rasLA1/+mice, K-rasLA1/+; Msh2−/− mice developed lung adenomas and adenocarcinomas at an increased frequency and also demonstrated evidence of accelerated adenocarcinoma growth.